Table 1.
Original publication | Guyot et al. (2012) | ipdfc | |
---|---|---|---|
Radiotherapy arm | Percent [95% CI] | Percent [95% CI] | |
Percent surviving one year | 55 | 56.1 [49.6, 63.3] | 56.9 [49.9, 63.2] |
Percent surviving two years | 41 | 41.1 [34.7, 48.6] | 40.9 [34.2, 47.5] |
Percent surviving three years | 34 | 34.7 [28.4, 42.5] | 33.5 [27.1, 40.1] |
Median duration | 14.9 | 14.9 [11.9, 23.0] | 16.1 [11.9, 20.4] |
Radiotherapy plus cetuximab arm | Percent [95% CI] | Percent [95% CI] | |
Survival rate at one year | 63 | 64.0 [57.8, 70.9] | 65.4 [58.2, 71.6] |
Survival rate at two years | 50 | 50.4 [43.9, 57.8] | 51.0 [43.3, 58.6] |
Survival rate at three years | 47 | 46.7 [40.1, 54.4] | 49.6 [40.4, 55.7] |
Median duration | 24.4 | 24.3 [15.7, 45.7] | 23.7 [15.6, 46.8] |
Hazard ratio with 95% CI | |||
0.68 [0.52, 0.89] | 0.73 [0.57, 0.94] | 0.72 [0.56, 0.93] |